Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma

BACKGROUND: Ovarian carcinoma is highly dependent on the ubiquitin proteasome system (UPS), but its clinical response to treatment with the proteasome inhibitor bortezomib has been disappointing. This has driven exploration of alternate approaches to target the UPS in ovarian cancer. Recently, prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Rosie T., Yemelyanova, Anna, Xing, Deyin, Anchoori, Ravi K., Hamazaki, Jun, Murata, Shigeo, Seidman, Jeffrey D., Wang, Tian-Li, Roden, Richard B. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547474/
https://www.ncbi.nlm.nih.gov/pubmed/28784174
http://dx.doi.org/10.1186/s13048-017-0347-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547474/
https://www.ncbi.nlm.nih.gov/pubmed/28784174
http://dx.doi.org/10.1186/s13048-017-0347-y

Ejemplares similares